{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:55:17Z","timestamp":1790553317731,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Crown Princess Margareta's Foundation"},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["2012-2472"],"award-info":[{"award-number":["2012-2472"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.exer.2014.06.006","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T11:59:18Z","timestamp":1403611158000},"page":"118-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4119-445X","authenticated-orcid":false,"given":"Pierfrancesco","family":"Mirabelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice B.","family":"Peebo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8722-9155","authenticated-orcid":false,"given":"Maria","family":"Xeroudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Koulikovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Lagali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2014.06.006_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1684\/ecn.2009.0175","article-title":"Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist","volume":"20","author":"Alessi","year":"2009","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.exer.2014.06.006_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/02713680903429007","article-title":"Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a corneal model","volume":"35","author":"Avisar","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2014.06.006_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/ICO.0b013e318159019f","article-title":"Subconjunctival bevacizumab injection for corneal neovascularization","volume":"27","author":"Bahar","year":"2008","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2014.06.006_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1463-5224.2010.00851.x","article-title":"Tissue distribution of dexamethasone in feline ocular structures following single topical application of dexamethasone as an ointment or suspension","volume":"14","author":"Bessonova","year":"2011","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib5","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"Bock","year":"2007","journal-title":"Investig. Ophthlamol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib6","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1167\/iovs.10-6101","article-title":"Time-lapse in\u00a0vivo imaging of corneal angiogenesis: the role of inflammatory cells in capillary sprouting","volume":"52","author":"Bourghardt Peebo","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0420.2006.00861.x","article-title":"Expression of the focal adhesion protein PINCH in normal and alkali-injured corneas and the role of PMNs","volume":"85","author":"Bourghardt Peebo","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.exer.2014.06.006_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","article-title":"Angiogenesis in life, disease and medicine","volume":"438","author":"Carmeliet","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exer.2014.06.006_bib9","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib11","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","article-title":"Subconjunctival injection of bevacizumab (Avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis","volume":"50","author":"Chen","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ajo.2012.06.007","article-title":"Short-term topical bevacizumab in the treatment of stable corneal neovascularization","volume":"154","author":"Cheng","year":"2012","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib13","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/ICO.0b013e318241433b","article-title":"Treatment of corneal neovascularization by topical application of ascorbic acid in the rabbit model","volume":"31","author":"Chung","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2014.06.006_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ICO.0b013e3181b1c82f","article-title":"The effect of subconjunctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits","volume":"29","author":"Chung","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2014.06.006_bib15","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.4049\/jimmunol.154.9.4719","article-title":"Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes","volume":"154","author":"Cox","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.exer.2014.06.006_bib16","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.exer.2014.06.006_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib18","first-page":"2326","article-title":"Effect of subconjunctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization","volume":"15","author":"Dratviman-Storobinsky","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2014.06.006_bib19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood-2006-02-001115","article-title":"Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes","volume":"109","author":"Ehrchen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exer.2014.06.006_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00003226-200101000-00018","article-title":"Leukocytes in the early events of corneal neovascularization","volume":"20","author":"Fagerholm","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2014.06.006_bib21","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1182\/blood-2009-12-257832","article-title":"Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction","volume":"116","author":"Fantin","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exer.2014.06.006_bib22","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1755-3768.2009.01585.x","article-title":"Subconjunctival bevacizumab for corneal neovascularization","volume":"88","author":"Farid","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib23","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.lpm.2012.02.001","article-title":"Eye and corticosteroid's use","volume":"41","author":"Fel","year":"2012","journal-title":"Presse Med."},{"key":"10.1016\/j.exer.2014.06.006_bib24","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F","article-title":"Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1","volume":"82","author":"Goede","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.exer.2014.06.006_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00441-009-0908-5","article-title":"Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in\u00a0vivo corneal model","volume":"339","author":"Gong","year":"2010","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.exer.2014.06.006_bib26","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1442-9071.2010.02252.x","article-title":"Inhibition of corneal neovascularization after alkali burn: comparison of different doses of bevacizumab in monotherapy or associated with dexamethasone","volume":"38","author":"Hoffart","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","article-title":"Suppression of inflammatory corneal lymphagniogenesis by application of topical corticosteroids","volume":"129","author":"Hos","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/ICO.0b013e31822480f9","article-title":"Anti-VEGF therapy with bevacizumab for anterior segment eye disease","volume":"31","author":"Hosseini","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2014.06.006_bib29","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.2353\/ajpath.2009.080819","article-title":"Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis","volume":"174","author":"Kim","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2014.06.006_bib30","first-page":"786870","article-title":"Anti-VEGF treatment strategies for wet AMD","author":"Kovach","year":"2012","journal-title":"J.\u00a0Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib31","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short and long term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization","volume":"247","author":"K\u00f6nig","year":"2009","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib32","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1167\/iovs.05-1193","article-title":"Two waves of neutrophil emigration in response to corneal epithelial abrasion: distinct adhesion molecule requirements","volume":"47","author":"Li","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib33","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1167\/iovs.10-5548","article-title":"Critical role of TNF-\u03b1-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization","volume":"53","author":"Lu","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib34","first-page":"1614","article-title":"Essential contribution of CCL3 to alkali-induced corneal neovascularization by regulating vascular endothelial growth factor production by macrophages","volume":"14","author":"Lu","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2014.06.006_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/bjo.2006.107912","article-title":"Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)","volume":"91","author":"Manzano","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib36","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1172\/JCI23874","article-title":"Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages","volume":"115","author":"Maruyama","year":"2005","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.exer.2014.06.006_bib37","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1167\/iovs.07-1329","article-title":"Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonide","volume":"49","author":"McKay","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.20022","article-title":"Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images","volume":"58","author":"Meijering","year":"2004","journal-title":"Cytom. Part A"},{"key":"10.1016\/j.exer.2014.06.006_bib39","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1167\/iovs.11-8114","article-title":"Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltration","volume":"53","author":"Nakao","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib40","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2353\/ajpath.2007.070172","article-title":"Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis","volume":"171","author":"Nakao","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2014.06.006_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02713680802607740","article-title":"The anti-inflammatory effect of subconjunctival bevacizumab on chemically burned rat corneas","volume":"34","author":"Oh","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2014.06.006_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10456-011-9223-3","article-title":"Cellular level characterization of capillary regression in inflammatory angiogenesis using an in\u00a0vivo corneal model","volume":"14","author":"Peebo","year":"2011","journal-title":"Angiogenesis"},{"key":"10.1016\/j.exer.2014.06.006_bib43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1167\/iovs.09-4407","article-title":"Cellular-level characterization of lymph vessels in live, un-labeled corneas by in\u00a0vivo confocal microscopy","volume":"51","author":"Peebo","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjophthalmol-2012-302137","article-title":"Subconjunctival bevacizumab induces regression of corneal neovascularisation: a pilot randomized placebo-controlled double-masked trial","volume":"97","author":"Petsoglou","year":"2013","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib45","first-page":"104","article-title":"Effects of rat anti-VEGF antibody in a rat model of corneal graft rejection by topical and subconjunctival route","volume":"17","author":"Rocher","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2014.06.006_bib46","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1167\/iovs.03-0097","article-title":"Macrophage depletion inhibits experimental choroidal neovascularization","volume":"44","author":"Sakurai","year":"2003","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib47","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3109\/02713683.2011.601840","article-title":"The impact of subconjunctivally injected EGF and VEGF inhibitors on experimental corneal neovascularization in rat model","volume":"36","author":"Sener","year":"2011","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2014.06.006_bib48","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/039463201302600206","article-title":"Vascular endothelial growth factor (VEGF), mast cells and inflammation","volume":"26","author":"Shaik-Dasthagirisaheb","year":"2013","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.exer.2014.06.006_bib49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/187221309789257450","article-title":"Corneal neovascularization: molecular events and therapeutic options","volume":"3","author":"Shakiba","year":"2009","journal-title":"Recent Pat. Inflamm. Allergy Drug. Discov."},{"key":"10.1016\/j.exer.2014.06.006_bib50","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal Neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2014.06.006_bib51","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1073\/pnas.0611177104","article-title":"The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching","volume":"104","author":"Suchting","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2014.06.006_bib52","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/jlb.55.3.410","article-title":"Macrophages and angiogenesis","volume":"55","author":"Sunderk\u00f6tter","year":"1994","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.exer.2014.06.006_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10555-011-9281-4","article-title":"Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy","volume":"30","author":"Tartour","year":"2011","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.exer.2014.06.006_bib54","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.semcancer.2013.02.003","article-title":"Neutrophil-mediated tumour angiogenesis: Subversion of immune responses to promote tumour growth","volume":"23","author":"Tazzyman","year":"2013","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.exer.2014.06.006_bib55","first-page":"3282","article-title":"Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer","volume":"6","author":"Ueno","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.exer.2014.06.006_bib56","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1016\/j.actbio.2013.01.022","article-title":"Macrophage phenotypes in the collagen-induced foreign body reaction in rats","volume":"9","author":"van Putten","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.exer.2014.06.006_bib57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1590\/S0004-27492012000400012","article-title":"Intrastromal injection of bevacizumab in patients with corneal neovascularization","volume":"75","author":"Vieira","year":"2012","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.exer.2014.06.006_bib58","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1167\/iovs.08-1678","article-title":"Retinal vascular caliber changes after intravitreal triamcinolone treatment for diabetic macular edema","volume":"49","author":"Wickremasinghe","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2014.06.006_bib59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/s-0032-1315249","article-title":"Inflammatory choroidal neovascularization","volume":"229","author":"Winterhalter","year":"2012","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"10.1016\/j.exer.2014.06.006_bib60","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1600-0420.2007.01049.x","article-title":"Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn","volume":"86","author":"Yoeruek","year":"2008","journal-title":"Acta Ophthalmol."},{"issue":"5","key":"10.1016\/j.exer.2014.06.006_bib61","doi-asserted-by":"crossref","first-page":"e36451","DOI":"10.1371\/journal.pone.0036451","article-title":"Human tears reveal insights into corneal neovascularization","volume":"7","author":"Zakaria","year":"2012","journal-title":"PLoS One"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483514001675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483514001675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:56:11Z","timestamp":1689332171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483514001675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":61,"alternative-id":["S0014483514001675"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2014.06.006","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early effects of dexamethasone and anti-VEGF therapy in an inflammatory corneal neovascularization model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2014.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}